Literature DB >> 1417774

Biosynthesis of heparin. The D-glucuronosyl- and N-acetyl-D-glucosaminyltransferase reactions and their relation to polymer modification.

K Lidholt1, U Lindahl.   

Abstract

Oligosaccharides with the general structure [GlcA-GlcNAc]n-GlcA-aMan (aMan is 2,5-anhydro-D-mannose), derived from the Escherichia coli K5 capsular polysaccharide, were found to serve as monosaccharide acceptors for a GlcNAc-transferase, solubilized from a mouse mastocytoma microsomal fraction and implicated in heparin biosynthesis. Digestion of these oligosaccharides with beta-D-glucuronidase yielded acceptors for the GlcA-transferase that acts in concert with the GlcNAc-transferase. Assays based on the oligosaccharide acceptors showed broad pH optima for the two enzymes, centred around pH 6.5 for the GlcNAc-transferase and around pH 7.0 for the GlcA-transferase. The GlcNAc-transferase showed an absolute requirement for Mn2+, whereas the GlcA-transferase was stimulated by Ca2+ and Mg2+ but not by Mn2+. The GlcNAc acceptor ability of the [GlcA-GlcNAc]n-GlcA-aMan oligosaccharides increased with increasing chain length, as reflected by the apparent Km, which was 60 microM for a hexasaccharide but 6 microM for a hexadecasaccharide. By contrast, the Km for [GlcNAc-GlcA]n-aMan oligosaccharides in the GlcA-transferase reaction was higher, approximately 0.5 mM, and unaffected by acceptor size. After chemical modification of the oligosaccharides to obtain mixed N-substituents (N-unsubstituted, N-acetylated or N-sulphated GlcN residues), GlcNAc transfer was found to be virtually independent of the N-substituent pattern of the acceptor sequence. The GlcA-transferase, on the other hand, showed marked preference for an acceptor with a non-reducing-terminal GlcNAc-GlcA-GlcNSO3- sequence, which would thus have a lower Km for the enzyme than the corresponding fully N-acetylated structure. These results, along with our previous finding that chain elongation in a mastocytoma microsomal system is strongly promoted by concomitant N-sulphation of the nascent chain [Lidholt, Kjellén & Lindahl (1989) Biochem. J. 261, 999-1007], raise the possibility that the glycosyltransferases and the N-deacetylase/N-sulphotransferase act in concert during chain elongation, assembled into an enzyme complex.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1417774      PMCID: PMC1133118          DOI: 10.1042/bj2870021

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  32 in total

1.  Biosynthesis of heparin. Relationship between the polymerization and sulphation processes.

Authors:  K Lidholt; L Kjellén; U Lindahl
Journal:  Biochem J       Date:  1989-08-01       Impact factor: 3.857

2.  Formation of anhydrosugars in the chemical depolymerization of heparin.

Authors:  J E Shively; H E Conrad
Journal:  Biochemistry       Date:  1976-09-07       Impact factor: 3.162

3.  Inhibition of synthesis of heparan sulfate by selenate: possible dependence on sulfation for chain polymerization.

Authors:  C P Dietrich; H B Nader; V Buonassisi; P Colburn
Journal:  FASEB J       Date:  1988-01       Impact factor: 5.191

Review 4.  Structure and function of heparan sulphate proteoglycans.

Authors:  J T Gallagher; M Lyon; W P Steward
Journal:  Biochem J       Date:  1986-06-01       Impact factor: 3.857

5.  Biosynthesis of heparin. Solubilization and partial purification of uridine diphosphate glucuronic acid: acceptor glucuronosyltransferase from mouse mastocytoma.

Authors:  T Helting
Journal:  J Biol Chem       Date:  1972-07-10       Impact factor: 5.157

6.  Relationship of sulfation to ongoing chondroitin polymerization during biosynthesis of chondroitin 4-sulfate by microsomal preparations from cultured mouse mastocytoma cells.

Authors:  G Sugumaran; J E Silbert
Journal:  J Biol Chem       Date:  1990-10-25       Impact factor: 5.157

7.  Biosynthesis of heparin. Purification of a 110-kDa mouse mastocytoma protein required for both glucosaminyl N-deacetylation and N-sulfation.

Authors:  I Pettersson; M Kusche; E Unger; H Wlad; L Nylund; U Lindahl; L Kjellén
Journal:  J Biol Chem       Date:  1991-05-05       Impact factor: 5.157

8.  Biosynthesis of heparin. Modulation of polysaccharide chain length in a cell-free system.

Authors:  K Lidholt; J Riesenfeld; K G Jacobsson; D S Feingold; U Lindahl
Journal:  Biochem J       Date:  1988-09-01       Impact factor: 3.857

9.  Structure and affinity for antithrombin of heparan sulfate chains derived from basement membrane proteoglycans.

Authors:  G Pejler; G Bäckström; U Lindahl; M Paulsson; M Dziadek; S Fujiwara; R Timpl
Journal:  J Biol Chem       Date:  1987-04-15       Impact factor: 5.157

10.  Presence of unsulfated heparan chains on the heparan sulfate proteoglycan of human colon carcinoma cells. Implications for heparan sulfate proteoglycan biosynthesis.

Authors:  R V Iozzo
Journal:  J Biol Chem       Date:  1989-02-15       Impact factor: 5.157

View more
  13 in total

1.  Structural domains of heparan sulphate for specific recognition of the C-terminal heparin-binding domain of human plasma fibronectin (HEPII).

Authors:  A Walker; J T Gallagher
Journal:  Biochem J       Date:  1996-08-01       Impact factor: 3.857

2.  Role of heparan sulfate domain organization in endostatin inhibition of endothelial cell function.

Authors:  Johan Kreuger; Taro Matsumoto; Maarten Vanwildemeersch; Takako Sasaki; Rupert Timpl; Lena Claesson-Welsh; Dorothe Spillmann; Ulf Lindahl
Journal:  EMBO J       Date:  2002-12-02       Impact factor: 11.598

3.  Biosynthesis of heparin/heparan sulphate: mechanism of epimerization of glucuronyl C-5.

Authors:  A Hagner-Mcwhirter; U Lindahl; J p Li
Journal:  Biochem J       Date:  2000-04-01       Impact factor: 3.857

4.  Assessment of glycosaminoglycan-protein linkage tetrasaccharides as acceptors for GalNAc- and GlcNAc-transferases from mouse mastocytoma.

Authors:  K Lidholt; M Fjelstad; U Lindahl; F Goto; T Ogawa; H Kitagawa; K Sugahara
Journal:  Glycoconj J       Date:  1997-09       Impact factor: 2.916

Review 5.  Heparan sulfate biosynthesis: regulation and variability.

Authors:  Johan Kreuger; Lena Kjellén
Journal:  J Histochem Cytochem       Date:  2012-10-04       Impact factor: 2.479

6.  Heparin proteoglycans synthesized by mouse mastocytoma contain chondroitin sulphate.

Authors:  K Lidholt; I Eriksson; L Kjellén
Journal:  Biochem J       Date:  1995-10-01       Impact factor: 3.857

7.  Sulphated and undersulphated heparan sulphate proteoglycans in a Chinese hamster ovary cell mutant defective in N-sulphotransferase.

Authors:  K J Bame; L Zhang; G David; J D Esko
Journal:  Biochem J       Date:  1994-10-01       Impact factor: 3.857

8.  Characterization of heparin oligosaccharides binding specifically to antithrombin III using mass spectrometry.

Authors:  Hicham Naimy; Nancy Leymarie; Michael J Bowman; Joseph Zaia
Journal:  Biochemistry       Date:  2008-02-09       Impact factor: 3.162

9.  Structure of heparan sulphate from human brain, with special regard to Alzheimer's disease.

Authors:  B Lindahl; L Eriksson; U Lindahl
Journal:  Biochem J       Date:  1995-02-15       Impact factor: 3.857

10.  NDST2 (N-Deacetylase/N-Sulfotransferase-2) Enzyme Regulates Heparan Sulfate Chain Length.

Authors:  Audrey Deligny; Tabea Dierker; Anders Dagälv; Anders Lundequist; Inger Eriksson; Alison V Nairn; Kelley W Moremen; Catherine L R Merry; Lena Kjellén
Journal:  J Biol Chem       Date:  2016-07-07       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.